Investigative Site

Dallas, Texas 75390

0 studies enrolling now · 15 studies all time

What they study most

Alport Syndrome, Chemotherapy Induced Anemia, Covid19, Diabetic Macular Edema, Focal Segmental Glomerulosclerosis, Healthy, Heavy Menstrual Bleeding, Hereditary Hemochromatosis, Influenza A, Lumbosacral Radiculopathy, Menorrhagia, Obesity

Studies at this site

• Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus — Completed
• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis — Completed
• A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A — Stopped early
• A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) — Running, not enrolling
• Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012) — Stopped early
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab — Completed
• A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis — Completed
• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis — Completed
• Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy — Completed
• Efficacy and Safety Study of XP12B in Women With Menorrhagia — Completed
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder — Completed
• Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects — Completed